BGM1812 is named as a drug or biological intervention in 2 clinical trials in our USA and China trial registers, 2 of which are recruiting. The lead sponsor is BrightGene Bio-Medical Technology Co., Ltd.. Registered phase: Phase 1. Conditions studied include Overweight or Obesity; Healhty.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07224399 | Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women (ClinicalTrials.gov ↗) Healhty, Overweight or Obesity |
Phase 1 | Recruiting |
| NCT07294235 | A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants (ClinicalTrials.gov ↗) Overweight or Obesity |
Phase 1 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Overweight or Obesity | 2 |
| Healhty | 1 |
| Lead sponsor | Trials |
|---|---|
| BrightGene Bio-Medical Technology Co., Ltd. | 2 |
| Register | BGM1812 trials |
|---|---|
| Clinical trials in USA | 1 |
| Clinical trials in China | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how BGM1812 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists BGM1812 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.